Myocardial sympathetic innervation in diabetic patients with symptomatic coronary artery disease

被引:3
|
作者
Fricke, E. [1 ]
Eckert, S. [2 ]
Fricke, H. [1 ]
Koerfer, J. [1 ]
Weisel, R. [1 ]
Lindner, O. [1 ]
Tschoepe, D. [3 ]
Horstkotte, D. [2 ]
Burchert, W. [1 ]
机构
[1] Hertz & Diabet Zentrum Nordrhein Westfalen, Inst Radiol Nukl Med & Mol Bildgebung, D-32545 Bad Oeynhausen, Germany
[2] Hertz & Diabet Zentrum Nordrhein Westfalen, Dept Cardiol, D-32545 Bad Oeynhausen, Germany
[3] Hertz & Diabet Zentrum Nordrhein Westfalen, Ctr Diabet, D-32545 Bad Oeynhausen, Germany
来源
NUKLEARMEDIZIN-NUCLEAR MEDICINE | 2008年 / 47卷 / 01期
关键词
diabetes mellitus; coronary heart disease; sympathetic nervous system; ischoemia; positron emission tomography;
D O I
10.3413/nukmed-0102
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Aim: In non-diabetic patients, sympathetic innervation can be preserved even if there is major impairment of myocardial blood supply. Matters may be more complex in diabetic patients because denervation can be caused by (cardiac autonomic neuropathy (CAN) or by ischemic injury. Our aim was to determine whether restrictions in myocardial blood supply have a pronounced influence on sympathetic innervation in diabetics and if this effect can be differentiated from CAN. Patients, methods: We analyzed 20 diabetics with advanced coronary artery disease (CAD) and without known CAN. We determined quantitative myocardial blood flow using N-13-ammonia-PET, myocardial viability with F-18-FDG, and cardiac innervation with C-11-HED. We investigated the relationship between regional HED retention, blood flow, and coronary flow reserve (CFR). Attenuated heart rate response to adenosine was taken as indicator for CAN (HR ratio). Results: There was minor correlation of segmental stress flow and HED retention (r(2) = 0.063, p < 0.0001). Correlation improved when stress flow as well as HED retention were normalized to the individual maximum (r(2) = 0.162, p < 0.0001). In nine patients, a HR ratio < 1.2 implicated subdinical CAN. Duration of diabetic disease or glycaemic control (HbAlc) did not correlate with mean HED retention in the viable segments, but with its voriation coefficient. Conclusions: As in non-diabetic patients, a slight correlation exists between CFR and sympathetic innervation. The sensitivity of sympathetic nerves to reductions in CFR does not seem to be increased as compared to the results reported for non-diabetics. Besides impaired blood supply, long duration of diabetic disease and bad glycaemic control also seem to impair sympathetic innervation provoking higher heterogeneity.
引用
收藏
页码:24 / 29
页数:6
相关论文
共 50 条
  • [1] Myocardial sympathetic innervation in patients with symptomatic coronary artery disease: Follow-up after 1 year with neuro stimulation
    Fricke, Eva
    Eckert, Siegfried
    Dongas, Aristidis
    Fricke, Harald
    Preuss, Rainer
    Lindner, Oliver
    Horstkotte, Dieter
    Burchert, Wolfgang
    JOURNAL OF NUCLEAR MEDICINE, 2008, 49 (09) : 1458 - 1464
  • [2] Myocardial sympathetic innervation in patients with chronic coronary artery disease: is reduction in coronary flow reserve correlated with sympathetic denervation?
    Eva Fricke
    Harald Fricke
    Siegfried Eckert
    Sytze Zijlstra
    Reiner Weise
    Oliver Lindner
    Dieter Horstkotte
    Wolfgang Burchert
    European Journal of Nuclear Medicine and Molecular Imaging, 2007, 34 : 206 - 211
  • [3] Myocardial sympathetic innervation in patients with chronic coronary artery disease: is reduction in coronary flow reserve correlated with sympathetic denervation?
    Fricke, Eva
    Fricke, Harald
    Eckert, Siegfried
    Zijlstra, Sytze
    Weise, Reiner
    Lindner, Oliver
    Horstkotte, Dieter
    Burchert, Wolfgang
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 (02) : 206 - 211
  • [4] Alterations of myocardial presynaptic sympathetic innervation in patients with multi-vessel coronary artery disease but without history of myocardial infarction
    Bülow, HP
    Stahl, F
    Lauer, B
    Nekolla, SG
    Schuler, G
    Schwaiger, M
    Bengel, FM
    NUCLEAR MEDICINE COMMUNICATIONS, 2003, 24 (03) : 233 - 239
  • [5] Less revascularization in diabetic patients with silent myocardial ischemia results poor survival compared to diabetic patients with symptomatic coronary artery disease
    Choi, EK
    Koo, SK
    Cho, YS
    Kang, HJ
    Chung, WY
    Youn, TJ
    Chae, IH
    Choi, DJ
    Kim, HS
    Oh, BH
    Park, YB
    Choi, YS
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (04) : 163A - 163A
  • [6] No difference in cardiac innervation of diabetic patients with painful and asymptomatic coronary artery disease
    Koistinen, MJ
    Airaksinen, KEJ
    Huikuri, HV
    Linnaluoto, MMK
    Heikkila, J
    Torniainen, P
    Ahonen, A
    DIABETES CARE, 1996, 19 (03) : 231 - 235
  • [7] Effect of free fatty acid inhibition on silent and symptomatic myocardial ischemia in diabetic patients with coronary artery disease
    Marazzi, Giuseppe
    Wajngarten, Mauricio
    Vitale, Cristiana
    Patrizi, Roberto
    Pelliccia, Francesco
    Gebara, Otavio
    Pierri, Humberto
    Ramires, Jose Antonio F.
    Volterrani, Maurizio
    Fini, Massimo
    Rosano, Giuseppe M. C.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2007, 120 (01) : 79 - 84
  • [8] Effect of free fatty acid inhibition on silent and symptomatic myocardial ischemia in diabetic patients with coronary artery disease
    Rosano, GM
    Wajngarten, M
    Vitale, C
    Gebara, O
    Marazzi, G
    Fini, M
    Volterrani, M
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (04) : 218A - 218A
  • [9] Symptomatic refractory myocardial ischemia in coronary artery disease
    Leschke, M
    Schoebel, FC
    Strauer, BE
    INTERNIST, 1996, 37 (06): : 597 - 606
  • [10] Myocardial presynaptic sympathetic innervation evaluated with 11C-HED-PET in patients with severe coronary artery disease but no history of myocardial infarction.
    Bülow, H
    Stahl, F
    Lauer, B
    Nekolla, SG
    Schuler, G
    Schwaiger, M
    Bengel, F
    JOURNAL OF NUCLEAR MEDICINE, 2002, 43 (05) : 184P - 184P